Ïã¸Û±¦µäÃâ·Ñ×ÊÁÏ´óÈ«

Ïã¸Û±¦µäÃâ·Ñ×ÊÁÏ´óÈ« universities are part of a major new international project, funded by the US Food and Drug Administration (FDA) to improve our understanding of severe coronavirus infection in humans. The three-year project will bring together collaborators from the University of Liverpool, Public Health England, the University of Bristol (Dr David Matthews and Dr Andrew Davidson), the University of Oxford, A*STAR in Singapore, and King Fahd Medical City in Saudi Arabia.

The study will aim to create profiles of various coronaviruses, including SARS-CoV-2 which causes Covid-19, to inform the development of treatments and vaccines. The study will also examine newly developed technologies such as organ-on-chips to rapidly characterise coronaviruses/novel diseases and medical countermeasures.

This international collaboration builds on existing expertise in Ïã¸Û±¦µäÃâ·Ñ×ÊÁÏ´óÈ« universities while contributing to the global fight against Covid-19.Ìý

Read more:

Related case studies

First detection of gases in super-Earth atmosphere

An EU-funded project led by researchers from University College London (UCL) examined the atmosphere of the super-Earth planet 55 Cancri e in unprecedented detail including the first successful detection of gases in the atmosphere of a planet of this size.

Ìý

Read more >

Revolutionising industrial material processing

The integration of lasers into optical fibres by pioneering research at the University of Southampton has led to the creation of a new business sector in fibre laser technology and manufacturing, improving production and manufacturing processes for a huge range of industries.

Read more >